The SNP Gly388Arg at the transmembrane domain of FGFR4, a hot spot in RTKs, can enhance STAT3 activity by exposing a membrane proximal STAT3 binding site and finally accelerates cancer progression [18]. Here, STAT3 is linked to cancer.